Clinical Trial Update: A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore: [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating roflumilast for safety and effectiveness in chronic obstructive pulmonary disease completed in China, Hong Kong, and Singapo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Phase 3 | Status: COMPLETED | Results posted: 2013-08-02